Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

577
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
577
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

960
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
960
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

570
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
570
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

852
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
852
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

760
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
760

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

To disclose or not to disclose? Mental health service users' and practitioners' views of practitioners' own self-disclosure of mental health difficulties: A mixed-methods study.

PLOS mental health·2026
Same author

A Case Series Examining Clinic, Laboratory, and Physical Function After Administration of Nusinersen in Adults With Spinal Muscular Atrophy, a Single-Center Study.

Journal of clinical neuromuscular disease·2024
Same author

Exploring opportunities beyond clinical practice: The need for PA educators.

JAAPA : official journal of the American Academy of Physician Assistants·2024
Same author

When and How to Utilize Pudendal Nerve Blocks for Treatment of Pudendal Neuralgia.

Clinical obstetrics and gynecology·2022
Same author

A practical approach to selecting a colorectal cancer screening test.

JAAPA : official journal of the American Academy of Physician Assistants·2021
Same author

Preparedness for Clinical Practice and the Development of Professional Competencies.

The journal of physician assistant education : the official journal of the Physician Assistant Education Association·2019

Related Experiment Video

Updated: Feb 26, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.7K

A clinical update on ulcerative colitis for primary care.

Sarah Bolander1, Kimberly Carter, Tiffany Cooke

  • 1Sarah Bolander is an assistant professor at Northern Arizona University in Phoenix, AZ. Kimberly Carter is an associate professor and director of clinical education at Midwestern University in Glendale, AZ. Tiffany Cooke is an assistant clinical professor at Northern Arizona University. Nicole Hamilton is an assistant professor at Midwestern University. The authors have disclosed no potential conflicts of interest, financial or otherwise.

JAAPA : Official Journal of the American Academy of Physician Assistants
|February 24, 2026
PubMed
Summary

Ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD), requires early recognition for effective management. Advances in treatments, including biologics and small molecules, offer improved options for patients with this condition.

Keywords:
biologicsbiosimilarsgastrointestinalimmunomodulatorsinflammatory bowel diseaseulcerative colitis

More Related Videos

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

13.0K
Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.8K

Related Experiment Videos

Last Updated: Feb 26, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.7K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

13.0K
Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.8K

Area of Science:

  • Gastroenterology
  • Immunology

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) causing colon and rectal inflammation.
  • Symptoms like bloody diarrhea and abdominal pain significantly impair quality of life.

Purpose of the Study:

  • To highlight the critical need for early ulcerative colitis recognition.
  • To discuss recent therapeutic advances and the importance of individualized treatment selection.

Main Methods:

  • Review of current literature on ulcerative colitis management.
  • Analysis of novel pharmacologic and non-pharmacologic interventions.
  • Emphasis on a multidisciplinary approach to patient care.

Main Results:

  • Novel biologic agents, small molecules, and biosimilars have expanded treatment accessibility.
  • Treatment selection is tailored to disease severity, location, and patient needs.
  • Adjunctive therapies and a multidisciplinary team enhance comprehensive care.

Conclusions:

  • Optimizing therapy is key for inducing/maintaining remission, promoting mucosal healing, and preventing disease progression.
  • A collaborative, multidisciplinary approach is essential for improving long-term outcomes in ulcerative colitis patients.